Celldex Therapeutics (CLDX) Soars: Stock Adds 26.9% in Session - Tale of the Tape - Agenus (NASDAQ:AGEN), Celldex Therapeutics (NASDAQ:CLDX)

Celldex Therapeutics, Inc. CLDX was a big mover last session, as its shares rose nearly 27% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the healthcare company since Apr 23, as the stock is now trading above the volatile price range of $11.09 to $15.00.

In the last 30 days, the company witnessed four negative estimate revisions and the Zacks Consensus Estimate also moved lower, suggesting trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday's move higher lasts.

Celldex Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Better-ranked stocks in the medical sector include TrovaGene, Inc. TROV, ZIOPHARM Oncology, Inc. ZIOP and Agenus Inc. AGEN. All three sport a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report

AGENUS INC AGEN: Free Stock Analysis Report

CELLDEX THERAPT CLDX: Free Stock Analysis Report

TROVAGENE INC TROV: Get Free Report

ZIOPHARM ONCLGY ZIOP: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs